baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

SOL-GEL TECHN. IS-,10/ IL0011417206 /

5/24/2024 8:00:09 AM	Chg. +0.0050	Volume	Bid7:28:49 AM	Ask7:28:49 AM	High	Low
0.7050EUR	+0.71%	0 Turnover: 0.0000	0.7050Bid Size: 858	0.7750Ask Size: 780	0.7050	0.7050

GlobeNewswire 5/20 Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates

GlobeNewswire 5/16 Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainl...

GlobeNewswire 4/1 Sol-Gel’s Collaboration Partner First-to-File ANDA Drug Product Generic to Zoryve® Cream

GlobeNewswire 3/13 Sol-Gel Reports Full-Year 2023 Financial Results and Corporate Developments

GlobeNewswire 11/30/2023 Sol-Gel Technologies Screens First Patient for SGT-610 Phase 3 Study

GlobeNewswire 11/28/2023 Sol-Gel Technologies Ltd to Host Virtual KOL Event on Gorlin Syndrome and the Upcoming Phase 3 Trial...

GlobeNewswire 11/9/2023 Sol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire 8/30/2023 Sol-Gel Technologies to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

GlobeNewswire 3/25/2022 Sol-Gel Technologies Announces U.S. Commercial Partner Galderma to Promote TWYNEO® at the American A...

GlobeNewswire 12/22/2021 Sol-Gel Technologies to Participate in Upcoming LifeSci Partners Corporate Access Event and H.C. Wai...

GlobeNewswire 11/11/2021 Sol-Gel Technologies Reports Third Quarter 2021 Financial Results and Highlights Recent Corporate De...

GlobeNewswire 11/9/2021 Sol-Gel Technologies to Present Live at Jefferies London Healthcare Conference

GlobeNewswire 11/4/2021 Sol-Gel Technologies Announces Sale of Generic Dermatology Portfolio to Partner Padagis for $21 Mill...

GlobeNewswire 9/22/2021 Sol-Gel Technologies to Present at Upcoming Cantor Virtual Global Healthcare Conference

GlobeNewswire 9/9/2021 Sol-Gel Technologies to Present at Upcoming H.C. Wainwright Global Investment Conference

GlobeNewswire 8/4/2021 Sol-Gel Technologies Reports Second Quarter 2021 Financial Results and Highlights Recent Corporate D...

GlobeNewswire 7/27/2021 Sol-Gel Technologies Announces FDA Approval of TWYNEO®

GlobeNewswire 7/20/2021 Sol-Gel Technologies to Report Second Quarter 2021 Financial Results on August 4th, 2021

GlobeNewswire 6/28/2021 Sol-Gel Announces Pipeline Update and Future Development Plans

GlobeNewswire 5/27/2021 Sol-Gel Technologies to Present at Upcoming Jefferies Healthcare Conference and Raymond James Human ...

GlobeNewswire 5/13/2021 Sol-Gel Technologies Reports First Quarter 2021 Financial Results and Corporate Update

GlobeNewswire 4/27/2021 Sol-Gel Technologies Provides Update on FDA Review of EPSOLAY®

GlobeNewswire 3/4/2021 Sol-Gel Technologies Reports Full Year 2020 Financial Results and Corporate Update

GlobeNewswire 2/24/2021 Sol-Gel Technologies to Present at Upcoming 2021 Raymond James Institutional Investors Conference an...

GlobeNewswire 1/11/2021 Sol-Gel Technologies to Present at Upcoming 2021 Solebury Trout Virtual Investor Conference and H.C....

SOL-GEL TECHN. IS-,10/ IL0011417206 /

If you wish to receive reply to your feedback, please provide your email address.